Valone FH - Search Results

1

A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone.

Valone FH, Kohler M, Fisher K, Hannigan J, Flam M, Gandara D, Hendrickson C, Richman E, Yu KP. Valone FH, et al. NCI Monogr. 1987;(5):175-7. NCI Monogr. 1987. PMID: 2963230 Clinical Trial.

2

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.

Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW Jr. Valone FH, et al. J Clin Oncol. 1989 Oct;7(10):1427-36. doi: 10.1200/JCO.1989.7.10.1427. J Clin Oncol. 1989. PMID: 2789272 Clinical Trial.

3

A northern California Oncology Group randomized trial of single agent 5-FU vs. high-dose folinic acid + 5-FU vs. methotrexate + 5-FU + folinic acid in patients with disseminated measurable large bowel cancer.

Valone FH, Wittlinger PS, Flam MS, Drakes T, Eisenberg PD, Hannigan J. Valone FH, et al. Adv Exp Med Biol. 1988;244:193-9. doi: 10.1007/978-1-4684-5607-3_20. Adv Exp Med Biol. 1988. PMID: 3073654 Clinical Trial. No abstract available.

4

Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignancies.

Valone FH, Gandara DR, Luce JA, Wall S, Perez EA, Braham N, George M, Letvak L. Valone FH, et al. Cancer Chemother Pharmacol. 1993;32(3):215-20. doi: 10.1007/BF00685838. Cancer Chemother Pharmacol. 1993. PMID: 8500227 Clinical Trial.

5

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.

Valone FH, Gandara DR, Deisseroth AB, Perez EA, Rayner A, Aronson FR, Luce J, Paradise C. Valone FH, et al. J Immunother (1991). 1991 Jun;10(3):207-13. doi: 10.1097/00002371-199106000-00007. J Immunother (1991). 1991. PMID: 1651106 Clinical Trial.

6

Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: results of a phase I/II study.

Gandara DR, Valone FH, Perez EA, Deisseroth AB, Roach M 3rd, Ahn DK, Phillips T. Gandara DR, et al. Among authors: valone fh. Int J Radiat Oncol Biol Phys. 1991 May;20(5):1047-52. doi: 10.1016/0360-3016(91)90203-g. Int J Radiat Oncol Biol Phys. 1991. PMID: 1850719 Clinical Trial.

7

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer.

Chong G, Bhatnagar A, Cunningham D, Cosgriff TM, Harper PG, Steward W, Bridgewater J, Moore M, Cassidy J, Coleman R, Coxon F, Redfern CH, Jones JJ, Hawkins R, Northfelt D, Sreedharan S, Valone F, Carmichael J. Chong G, et al. Ann Oncol. 2006 Mar;17(3):437-42. doi: 10.1093/annonc/mdj090. Epub 2005 Nov 25. Ann Oncol. 2006. PMID: 16311275 Free article. Clinical Trial.

8

A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.

Graziano SL, Valone FH, Herndon JE 2nd, Crawford J, Richards F 2nd, Rege VB, Clamon G, Green MR. Graziano SL, et al. Among authors: valone fh. Lung Cancer. 1996 Jun;14(2-3):315-29. doi: 10.1016/0169-5002(96)00556-9. Lung Cancer. 1996. PMID: 8794413 Clinical Trial.

9

Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.

O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB 3rd. O'Dwyer PJ, et al. Among authors: valone fh. J Clin Oncol. 2001 May 1;19(9):2413-21. doi: 10.1200/JCO.2001.19.9.2413. J Clin Oncol. 2001. PMID: 11331320 Clinical Trial.

10

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.

Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, Verjee SS, Jones LA, Hershberg RM. Small EJ, et al. Among authors: valone fh. J Clin Oncol. 2006 Jul 1;24(19):3089-94. doi: 10.1200/JCO.2005.04.5252. J Clin Oncol. 2006. PMID: 16809734 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters